American Liver Foundation

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma (GEA)
2024-03-01 00:00 - 2025-03-29 23:59 (America/New_York) | On-Demand
We've collaborated with Medscape Oncology Global and Hope for Stomach Cancer to present a CME opportunity for health care professionals seeking to better understand established and emerging data related to HER2-targeted therapies in GEA. This on-demand course is available for continuing education credit until 3/29/25.
Upon completion of this activity, participants will:

Have increased knowledge regarding the

Biological rationale for using bispecific antibodies to target HER2 in GEA

Have greater competence related to

Selecting the most appropriate anti-HER2 therapy for a patient with HER2-positive GEA
Managing adverse events associated with anti-HER2 therapies for patients with HER2-positive GEA

Demonstrate greater confidence in their ability to

Collaborate with the patient when developing a treatment plan for their HER2-positive GEA

Learn more and register for this course: https://liver.fyi/HER2GEA

Updates on Hepatitis B and C for Patients
2024-06-10 00:00 - 2024-09-30 23:59 | On-Demand

Liver Life Walk Connecticut
2024-09-28 00:00 - 23:59 | Meriden, CT
